← Eichor
Study identifier: NCT05685368 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease

Condition: Race-related Stress · Depression, Anxiety · Quality of Life  ·  Sponsor: Children's Hospital Los Angeles

PhasePhase 1/Phase 2
Planned participants66
Who can joinAll sexes, 14 Years to 21 Years
Healthy volunteersNo

About this study

The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study will consist of a small, purposeful, non-randomized sample (N = 30) of clients enrolled into a 10-session Acceptance and Commitment Therapy group. The group will be offered as part of regular clinical care at the Division of Adolescent and Young Adult Medicine. Three consecutive groups will be run with approximately 8-10 participants in each group over the next year.

This description comes directly from the study's public registry record.

Talk to the study team

Xzania Lee, PhD  ·  323.361.4768  ·  xlee@chla.usc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Children's Hospital Los AngelesLos Angeles, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05685368